Nascent Biotech Stock Technical Analysis
| NBIO Stock | USD 0.01 0 16.67% |
As of the 3rd of March, Nascent Biotech secures the Risk Adjusted Performance of 0.1104, downside deviation of 28.89, and Mean Deviation of 25.21. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nascent Biotech, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Nascent Biotech, which can be compared to its peers in the industry.
Nascent Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Nascent, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NascentNascent |
Nascent Biotech technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Nascent Biotech Technical Analysis
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Nascent Biotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Nascent Biotech Trend Analysis
Use this graph to draw trend lines for Nascent Biotech. You can use it to identify possible trend reversals for Nascent Biotech as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Nascent Biotech price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Nascent Biotech Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Nascent Biotech applied against its price change over selected period. The best fit line has a slop of 0.0012 , which may suggest that Nascent Biotech market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.05, which is the sum of squared deviations for the predicted Nascent Biotech price change compared to its average price change.About Nascent Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Nascent Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Nascent Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Nascent Biotech price pattern first instead of the macroeconomic environment surrounding Nascent Biotech. By analyzing Nascent Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Nascent Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Nascent Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
Nascent Biotech March 3, 2025 Technical Indicators
Most technical analysis of Nascent help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Nascent from various momentum indicators to cycle indicators. When you analyze Nascent charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1104 | |||
| Market Risk Adjusted Performance | (2.19) | |||
| Mean Deviation | 25.21 | |||
| Semi Deviation | 13.92 | |||
| Downside Deviation | 28.89 | |||
| Coefficient Of Variation | 732.63 | |||
| Standard Deviation | 82.37 | |||
| Variance | 6784.7 | |||
| Information Ratio | 0.1367 | |||
| Jensen Alpha | 11.12 | |||
| Total Risk Alpha | 13.8 | |||
| Sortino Ratio | 0.3896 | |||
| Treynor Ratio | (2.20) | |||
| Maximum Drawdown | 666.67 | |||
| Value At Risk | (14.45) | |||
| Potential Upside | 50.0 | |||
| Downside Variance | 834.84 | |||
| Semi Variance | 193.7 | |||
| Expected Short fall | (58.74) | |||
| Skewness | 7.37 | |||
| Kurtosis | 57.95 |
Other Information on Investing in Nascent OTC Stock
Nascent Biotech financial ratios help investors to determine whether Nascent OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nascent with respect to the benefits of owning Nascent Biotech security.